• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有复发事件和时间依存性区间删失标记数据的回归建模

Regression modeling with recurrent events and time-dependent interval-censored marker data.

作者信息

Chen Eric Bingshu, Cook Richard J

机构信息

Department of Statistics and Actuarial Science, University of Waterloo, 200 University Avenue West Waterloo, Ontario, Canada N2L 3G1.

出版信息

Lifetime Data Anal. 2003 Sep;9(3):275-91. doi: 10.1023/a:1025888820636.

DOI:10.1023/a:1025888820636
PMID:14649846
Abstract

In life history studies involving patients with chronic diseases it is often of interest to study the relationship between a marker process and a more clinically relevant response process. This interest may arise from a desire to gain a better understanding of the underlying pathophysiology, a need to evaluate the utility of the marker as a potential surrogate outcome, or a plan to conduct inferences based on joint models. We consider data from a trial of breast cancer patients with bone metastases. In this setting, the marker process is a point process which records the onset times and cumulative number of bone lesions which reflects the extent of metastatic bone involvement The response is also a point process, which records the times patients experience skeletal complications resulting from these bone lesions. Interest lies in assessing how the development of new bone lesions affects the incidence of skeletal complications. By considering the marker as an internal time-dependent covariate in the point process model for skeletal complications we develop and apply methods which allow one to express the association via regression. A complicating feature of this study is that new bone lesions are only detected upon periodic radiographic examination, which makes the marker processes subject to interval-censoring. A modified EM algorithm is used to deal with this incomplete data problem.

摘要

在涉及慢性病患者的生命历程研究中,研究标记过程与更具临床相关性的反应过程之间的关系通常很有意义。这种兴趣可能源于想要更好地理解潜在病理生理学的愿望、评估标记物作为潜在替代结局的效用的需求,或者基于联合模型进行推断的计划。我们考虑来自一项针对有骨转移的乳腺癌患者的试验的数据。在这种情况下,标记过程是一个点过程,它记录骨病变的发病时间和累积数量,反映转移性骨受累的程度。反应也是一个点过程,它记录患者经历由这些骨病变导致的骨骼并发症的时间。兴趣在于评估新骨病变的发展如何影响骨骼并发症的发生率。通过将标记物视为骨骼并发症点过程模型中随时间变化的内部协变量,我们开发并应用了一些方法,这些方法允许通过回归来表达这种关联。这项研究的一个复杂特征是,新骨病变仅在定期的影像学检查时才被检测到,这使得标记过程受到区间删失的影响。一种改进的期望最大化(EM)算法被用于处理这个不完全数据问题。

相似文献

1
Regression modeling with recurrent events and time-dependent interval-censored marker data.具有复发事件和时间依存性区间删失标记数据的回归建模
Lifetime Data Anal. 2003 Sep;9(3):275-91. doi: 10.1023/a:1025888820636.
2
Statistical methods for multivariate interval-censored recurrent events.多变量区间删失复发事件的统计方法
Stat Med. 2005 Mar 15;24(5):671-91. doi: 10.1002/sim.1936.
3
Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.乳腺癌初次骨转移复发时骨扫描异常数量的预后意义。
Cancer. 2001 Jan 1;91(1):17-24. doi: 10.1002/1097-0142(20010101)91:1<17::aid-cncr3>3.0.co;2-k.
4
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
5
Tests for multivariate recurrent events in the presence of a terminal event.存在终末事件时的多变量复发事件检验。
Biostatistics. 2004 Jan;5(1):129-43. doi: 10.1093/biostatistics/5.1.129.
6
A retrospective study of first indicators of breast cancer recurrence.一项关于乳腺癌复发首要指标的回顾性研究。
Oncology. 2000 Apr;58(3):185-90. doi: 10.1159/000012098.
7
Regression with incomplete covariates and left-truncated time-to-event data.带有不完全协变量和左截断生存时间数据的回归。
Stat Med. 2013 Mar 15;32(6):1004-15. doi: 10.1002/sim.5581. Epub 2012 Aug 28.
8
Analysis of interval-censored recurrent event processes subject to resolution.受分辨率影响的区间删失复发事件过程分析。
Biom J. 2015 Sep;57(5):725-42. doi: 10.1002/bimj.201400162. Epub 2015 Jul 7.
9
The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy.肿瘤标志物在骨闪烁显像不明确的乳腺癌患者预测骨转移中的作用。
Br J Cancer. 1999 Mar;79(9-10):1443-7. doi: 10.1038/sj.bjc.6690230.
10
Prospective Study of Serial F-FDG PET and F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer.前瞻性研究 F-FDG PET 和 F-氟化物 PET 预测骨转移乳腺癌患者的骨骼相关事件时间、进展时间和生存时间。
J Nucl Med. 2018 Dec;59(12):1823-1830. doi: 10.2967/jnumed.118.211102. Epub 2018 May 10.

引用本文的文献

1
A Correlated Random Effects Model for Non-homogeneous Markov Processes with Nonignorable Missingness.具有不可忽视缺失性的非齐次马尔可夫过程的相关随机效应模型。
J Multivar Anal. 2013 May;117:1-13. doi: 10.1016/j.jmva.2013.01.009.
2
Non-homogeneous Markov process models with informative observations with an application to Alzheimer's disease.具有信息性观测的非齐次马尔可夫过程模型及其在阿尔茨海默病中的应用
Biom J. 2011 May;53(3):444-63. doi: 10.1002/bimj.201000122. Epub 2011 Apr 14.
3
The analysis of multivariate recurrent events with partially missing event types.

本文引用的文献

1
Stochastic relaxation, gibbs distributions, and the bayesian restoration of images.随机松弛,吉布斯分布,以及贝叶斯图像恢复。
IEEE Trans Pattern Anal Mach Intell. 1984 Jun;6(6):721-41. doi: 10.1109/tpami.1984.4767596.
2
Applying the Cox proportional hazards model when the change time of a binary time-varying covariate is interval censored.当二元时变协变量的变化时间受到区间删失时应用Cox比例风险模型。
Biometrics. 1999 Jun;55(2):445-51. doi: 10.1111/j.0006-341x.1999.00445.x.
3
Methodology for treatment evaluation in patients with cancer metastatic to bone.
具有部分缺失事件类型的多元复发事件分析。
Lifetime Data Anal. 2009 Mar;15(1):41-58. doi: 10.1007/s10985-008-9091-3. Epub 2008 Jul 12.
骨转移癌患者治疗评估方法
J Natl Cancer Inst. 2001 Apr 4;93(7):534-8. doi: 10.1093/jnci/93.7.534.
4
Some remarks on failure-times, surrogate markers, degradation, wear, and the quality of life.关于失效时间、替代指标、退化、磨损及生活质量的一些评论。
Lifetime Data Anal. 1999 Dec;5(4):307-14. doi: 10.1023/a:1009684008455.
5
Failure inference from a marker process based on a bivariate Wiener model.基于二元维纳模型的标记过程的失效推断
Lifetime Data Anal. 1998;4(3):229-51. doi: 10.1023/a:1009617814586.
6
Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.帕米膦酸盐对转移性乳腺癌骨骼并发症的长期预防。方案19阿仑膦酸钠乳腺癌研究组
J Clin Oncol. 1998 Jun;16(6):2038-44. doi: 10.1200/JCO.1998.16.6.2038.
7
Models for residual time to AIDS.艾滋病剩余时间模型。
Lifetime Data Anal. 1996;2(1):31-49. doi: 10.1007/BF00128469.
8
Marker processes in survival analysis.生存分析中的标记过程。
Lifetime Data Anal. 1996;2(1):15-29. doi: 10.1007/BF00128468.
9
Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.帕米膦酸盐在降低乳腺癌伴溶骨性骨转移患者骨骼并发症方面的疗效。方案19阿仑膦酸钠乳腺癌研究组
N Engl J Med. 1996 Dec 12;335(24):1785-91. doi: 10.1056/NEJM199612123352401.